Electrophoresis of proteins in the normal cephalorhachidian liquid of children and adults;Electroforesis de proteínas en el líquido cefalorraquídeo normal de niños y adultos

Revista Mexicana de Neurociencia

Volumn 9, Issue 3, 2008, Pages 242-247

  González Quevedo, Monteagudo Alina ^a   Fernández Carriera, Rebeca ^a   León Ortiz, Mabel M ^b   González García, Sergio ^a   Irma Vicente, Valdés ^a  

^a INSTITUTO DE NEUROLOGÍA Y NEUROCIRUGÍA   (Cuba)

^b Hospital Fructuoso Rodríguez   (Cuba)

Author keywords

Cerebrospinal fluid proteins; Haptoglobins; Normal cerebrospinal fluid; Polycrylamide gel electrophoresis

Indexed keywords

ANAZOLENE SODIUM; HAPTOGLOBIN; PREALBUMIN;

ADULT; ARTICLE; BLOOD; CEREBROSPINAL FLUID; CHILD; FEMALE; GEL ELECTROPHORESIS; HUMAN; MALE; NORMAL HUMAN; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN ELECTROPHORESIS;

EID: 67651174030     PISSN: 16655044     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Reiber H, Peter JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. Journal of the Neurological Sciences 2001; 184: 101-122 (Pubitemid 32178265)
2. Fishman RA (ed.). Cerebrospinal fluid in diseases of the nervous system. 2nd. Ed. Philadelphia, Pennsylvania, W.B. Saunders Company; 1992.
3. Siegel GF, Agranoff BW, Albers RW, Fisher SK, Uhler MD (eds.). Blood-Brain-Cerebrospinal Fluid Barriers. In: Basic Neurochemistry. Lippincot-Raven Publishers; 1999.
4. Thompson EJ (ed.). The CSF proteins: a biochemical approach, Elsevier; 1988.
5. Saunders NR, Habgood MD, Dziegielewska KM. Barrier mechanisms in the brain. I. Adult brain. Clin Exp Pharmacol Physiol 1999; 26: 11-19.
6. Massaro AR, Scivoletto G, Tonali P. Cerebrospinal fluid markers in neurological diseases. Ital J Neurol Sci 1990; 11(6): 537-547
7. Takeoka T, Shinohara Y, Furumi K, Mori K. Characteristic protein fractions of cerebrospinal fluid disc electrophoresis analysis. Brain Res 1980; 198: 147-156 (Pubitemid 10002680)
8. Alekseeva LA, Sorokina MN. Diagnostic significance of the cerebrospinal fluid protein spectrum in bacterial and viral meningitis in children. Klin Lab Diagn 2001; 7: 15-19.
9. Burcet J, Zabay JM, Usón M, Mulet J, Figuerola A, Viander C. Síntesis Intratecal de IgG valorada mediante diferentes fórmula: Interés del análisis multivariante para el diagnóstico de esclerosis múltiple. Rev Neurol 2000; 31(9): 812-816
10. Masjuan J, Alvarez-Cermeño JC, García-Barragán N, Díaz-Sánchez M, Espiño M, Sádaba MC, et al. Clinically isolated syndromes. A new oligoclonal band test accurately predicts conversion to MS. Neurology 2006; 66: 576-578
11. Evans JH, Quick DT. Polyacrylamide gel electrophoresis of spinal fluid proteins. Arch Neurol 1966; 14: 64-71.
12. Cerda M, Vielma J, Basauri L. Electroforesis en gel de poliacrilamida de proteínas del líquido cefalorraquídeo. Neurocirugía 1978; 36(4): 330-333
13. Fernández CR, González-Quevedo A, Lara RR, León OMM, González GS, Valdés IV. Electroforesis de proteínas del líquido cefalorraquídeo en pacientes con enfermedad cerebrovascular isquémica. Rev Neurol 2002; 35(10): 908-912
14. Lowry OH, Rosebrugh RJ, Farr Al, Randal RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-275
15. Smith I (ed.). Chromatographic and electrophoretic techniques. Vol. II. Zone electrophoresis. Great Britain: Pitman Press; 1968.
16. Grabar P, Bartin P (eds.). Inmunoelectroforesis. Barcelona: Ed. Toray-Masson; 1968.
17. Seyfert S, Kunzmann V, Schwertfeger N, Koch HC, Faulstich A. Determinants of lumbar CSF protein concentration. J Neurol 2002; 249: 1021-1026
18. Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, et al. Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis. Arch Neurol 2005; 62: 865-870
19. Biou D, Benoist JF, Nguyen-Thi C, Huong X, Morel P, Marchand M. Cerebrospinal fluid protein concentrations in children: Age-related values in paients without disorders of the nervous system. Clin Chem 2000; 46(3): 399-403.
20. Saunders NR, Habgood MD, Dziegielewska KM. Barrier mechanisms in the brain, II. Immature brain. Clin Exp Pharmacol Physiol 1999; 26: 85-91.
21. Johansson PA, Dziegielewska KM, Ek CJ, Habgood MD, Liddelow SA, Potter AM, Stolp HB Saunders NR. Blood-CSF barrier function in the rat embryo. J Neuroscience 2006; 24: 65-76.
22. Tibbling G, Link H, Ohman S. Principles of albumin and IgG analysis in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 1977; 37: 385-390
23. Gerbaut L, Ponsot G (eds.). Interpretation of the protein profile of cerebrospinal fluid in children. In: Marker proteins in Inflammation. 1984; 2: 369-373
24. Cerda M, Vielma J, Martinez C, Basauri L. Polyacrylamide gel electrophoresis of cerebrospinal fluid proteins in children with nontumoral hydrocephalus. Child's Brain 1980; 6: 140-149 (Pubitemid 10151569)
25. Weisner B, Roethig HJ. The concentration of prealbumin in the cerebrospinal fluid (CSF), indicator of CSF circulation disorders. Eur Neurol 1983; 22: 96-105.
26. Strand T, Alling C, Karlsson B, Karlsson I, Winblad B. Brain and plasma proteins in spinal fluid as markers for brain damage and severity of stroke. Stroke 1984; 15(1): 138-144
27. Chamoun V, Zeman A, Blennow K, Fredman P, Wallin A, Keir G, et al. Haptoglobins as markers of blood-CSF barrier dysfunction: the findings in the normal CSF. J Neurol Sci 2001; 182(2): 117-121 (Pubitemid 33786707)